AMA statement on Biden decision to restore anti-bias protections
This move is a victory for health equity and ends a dismal chapter in which a federal agency sought to remove civil rights protections.
AMA statement on FDA decision on naloxone nasal
AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.
AMA statement on HHS decision to remove addiction treatment barriers
AMA is pleased that HHS will support physicians to prescribe buprenorphine, will remove daunting regulatory barriers for patients with opioid use disorder.
AMA statement on ACIP reaffirming J&J COVID-19 vaccine in U.S.
AMA commends ACIP for reaffirming its recommendation on the use of the J&J COVID-19 vaccine.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights
AMA member physicians get a 25% discount on own-specialty disability insurance premiums.Calculate Your Quote Now